医学
肠促胰岛素
肥胖
糖尿病
生物信息学
内科学
2型糖尿病
内分泌学
生物
出处
期刊:JAMA
[American Medical Association]
日期:2024-09-19
卷期号:332 (20): 1695-1695
被引量:4
标识
DOI:10.1001/jama.2024.17571
摘要
In this Viewpoint, 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of GLP-1 (7-37), the biologically active incretin that led to development of effective GLP-1 analogues for treating diabetes and obesity.
科研通智能强力驱动
Strongly Powered by AbleSci AI